These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9170398)

  • 1. Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Secondary Prevention Group.
    Ishikawa K; Nakai S; Takenaka T; Kanamasa K; Hama J; Ogawa I; Yamamoto T; Oyaizu M; Kimura A; Yamamoto K; Yabushita H; Katori R
    Circulation; 1997 May; 95(10):2368-73. PubMed ID: 9170398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of cancer in postmyocardial infarction patients treated with short-acting nifedipine and diltiazem. Secondary Prevention Group.
    Kanamasa K; Kimura A; Miyataka M; Takenaka T; Ishikawa K
    Cancer; 1999 Mar; 85(6):1369-74. PubMed ID: 10189144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium antagonists and myocardial infarction.
    Hansen JF
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):665-70. PubMed ID: 1888690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of calcium antagonist trials in acute myocardial infarction.
    Roberts R
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III41-7. PubMed ID: 2691141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT).
    Boden WE; van Gilst WH; Scheldewaert RG; Starkey IR; Carlier MF; Julian DG; Whitehead A; Bertrand ME; Col JJ; Pedersen OL; Lie KI; Santoni JP; Fox KM
    Lancet; 2000 May; 355(9217):1751-6. PubMed ID: 10832825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome with calcium channel antagonists after myocardial infarction: a community-based study.
    Leitch JW; McElduff P; Dobson A; Heller R
    J Am Coll Cardiol; 1998 Jan; 31(1):111-7. PubMed ID: 9426027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium antagonists for secondary prevention of myocardial infarction: is there a need to shift from short-acting to long-acting types?
    Taniwa T; Miyataka M; Kimura A; Taniguchi M; Hirano Y; Hayashi T; Ishikawa K
    Circ J; 2005 Nov; 69(11):1308-14. PubMed ID: 16247203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary prevention with calcium antagonists after acute myocardial infarction.
    Hansen JF
    Drugs; 1992; 44 Suppl 1():33-43. PubMed ID: 1283582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of diltiazem and verapamil on mortality and cardiac events in non-Q-wave acute myocardial infarction without pulmonary congestion: post hoc subset analysis of the multicenter diltiazem postinfarction trial and the second danish verapamil infarction trial studies.
    Gibson RS; Hansen JF; Messerli F; Schechtman KB; Boden WE
    Am J Cardiol; 2000 Aug; 86(3):275-9. PubMed ID: 10922432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium antagonists in secondary prevention after myocardial infarction.
    Persson S
    Drugs; 1991; 42 Suppl 2():54-60. PubMed ID: 1718702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium channel blockers in myocardial infarction.
    Skolnick AE; Frishman WH
    Arch Intern Med; 1989 Jul; 149(7):1669-77. PubMed ID: 2662933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of calcium antagonists in the treatment of myocardial ischemia.
    Follath F
    Am Heart J; 1989 Nov; 118(5 Pt 2):1093-6; discussion 1096-7. PubMed ID: 2683702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic effects of calcium channel blockers on cardiac events, stroke and end-stage renal disease in patients with angina pectoris. Retrospective comparative study of benidipine, diltiazem and nifedipine.
    Arioka I; Dohi S; Dohi S; Sakai K
    Arzneimittelforschung; 2008; 58(9):435-40. PubMed ID: 18972872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary note on the use of calcium antagonists in ischemic cardiopathy].
    Seu V; Abrile PG; Boero E; Magaia O; Mocini A; Castrignano A; Maffei P; Perugini P; Livi A
    Minerva Cardioangiol; 1984 Oct; 32(10):639-46. PubMed ID: 6396533
    [No Abstract]   [Full Text] [Related]  

  • 15. Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials.
    Opie LH
    Cardiovasc Drugs Ther; 1988 Jan; 1(5):461-91. PubMed ID: 3154677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of calcium channel blocking drugs after myocardial infarction.
    Moss AJ
    Eur Heart J; 1986 May; 7 Suppl A():31-4. PubMed ID: 3522237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of heart rate spectral analysis to study the effects of calcium channel blockers on sympathetic activity after myocardial infarction.
    Bekheit S; Tangella M; el-Sakr A; Rasheed Q; Craelius W; el-Sherif N
    Am Heart J; 1990 Jan; 119(1):79-85. PubMed ID: 2296878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symposium on Cardiovascular Disease and Calcium Antagonists. Introduction.
    Schwartz A
    Am J Cardiol; 1982 Feb; 49(3):497-8. PubMed ID: 7058761
    [No Abstract]   [Full Text] [Related]  

  • 19. What, if anything, is controversial about calcium antagonists?
    Messerli FH
    Am J Hypertens; 1996 Dec; 9(12 Pt 2):177S-181S. PubMed ID: 8968430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of calcium antagonists in ventricular dysfunction.
    Josephson MA; Singh BN
    Am J Cardiol; 1985 Jan; 55(3):81B-88B. PubMed ID: 3881919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.